SAN CARLOS, Calif.--(BUSINESS WIRE)--Cellerant Therapeutics Inc., a biotechnology company developing novel hematopoietic stem cell-based cellular and antibody therapies for blood disorders and cancer, announced today that Cellerant’s President and CEO, Ram Mandalam, Ph.D., will be presenting at the International Society for Stem Cell Research (ISSCR) 10th Annual Meeting held June 13 – 16 in Yokohama, Japan.
